Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis.
González-Ortega I, González-Pinto A, Alberich S, Echeburúa E, Bernardo M, Cabrera B, Amoretti S, Lobo A, Arango C, Corripio I, Vieta E, de la Serna E, Rodriguez-Jimenez R, Segarra R, López-Ilundain JM, Sánchez-Torres AM, Cuesta MJ; PEPs Group:; Zorrilla I, López P, Bioque M, Mezquida G, Barcones F, De-la-Cámara C, Parellada M, Espliego A, Alonso-Solís A, Grasa EM, Varo C, Montejo L, Castro-Fornieles J, Baeza I, Dompablo M, Torio I, Zabala A, Eguiluz JI, Moreno-Izco L, Sanjuan J, Guirado R, Cáceres I, Garnier P, Contreras F, Bobes J, Al-Halabí S, Usall J, Butjosa A, Sarró S, Landin-Romero R, Ibáñez A, Selva G. González-Ortega I, et al. Among authors: ibanez a. Psychol Med. 2020 Dec;50(16):2702-2710. doi: 10.1017/S0033291719002794. Epub 2019 Oct 22. Psychol Med. 2020. PMID: 31637990
Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study.
Torrent C, Bonnin Cdel M, Martínez-Arán A, Valle J, Amann BL, González-Pinto A, Crespo JM, Ibáñez Á, Garcia-Portilla MP, Tabarés-Seisdedos R, Arango C, Colom F, Solé B, Pacchiarotti I, Rosa AR, Ayuso-Mateos JL, Anaya C, Fernández P, Landín-Romero R, Alonso-Lana S, Ortiz-Gil J, Segura B, Barbeito S, Vega P, Fernández M, Ugarte A, Subirà M, Cerrillo E, Custal N, Menchón JM, Saiz-Ruiz J, Rodao JM, Isella S, Alegría A, Al-Halabi S, Bobes J, Galván G, Saiz PA, Balanzá-Martínez V, Selva G, Fuentes-Durá I, Correa P, Mayoral M, Chiclana G, Merchan-Naranjo J, Rapado-Castro M, Salamero M, Vieta E. Torrent C, et al. Among authors: ibanez a. Am J Psychiatry. 2013 Aug;170(8):852-9. doi: 10.1176/appi.ajp.2012.12070971. Am J Psychiatry. 2013. PMID: 23511717 Clinical Trial.
Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.
Solé B, Bonnin CM, Mayoral M, Amann BL, Torres I, González-Pinto A, Jimenez E, Crespo JM, Colom F, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, Soria S, Garcia-Portilla MP, Ibañez Á, Vieta E, Martinez-Aran A, Torrent C; CIBERSAM Functional Remediation Group. Solé B, et al. Among authors: ibanez a. Eur Neuropsychopharmacol. 2015 Feb;25(2):257-64. doi: 10.1016/j.euroneuro.2014.05.010. Epub 2014 May 20. Eur Neuropsychopharmacol. 2015. PMID: 24906790 Clinical Trial.
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
Usall J, López-Carrilero R, Iniesta R, Roca M, Caballero M, Rodriguez-Jimenez R, Oliveira C, Bernardo M, Corripio I, Sindreu SD, González Piqueras JC, Felipe AE, Fernandez de Corres B, Ibáñez A, Huerta R; Abordaje Síntomas Negativos Esquizofrenia Group. Usall J, et al. Among authors: ibanez a. J Clin Psychiatry. 2014 Jun;75(6):608-15. doi: 10.4088/JCP.13m08551. J Clin Psychiatry. 2014. PMID: 25004184 Clinical Trial.
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
Cuesta MJ, Sánchez-Torres AM, Cabrera B, Bioque M, Merchán-Naranjo J, Corripio I, González-Pinto A, Lobo A, Bombín I, de la Serna E, Sanjuan J, Parellada M, Saiz-Ruiz J, Bernardo M; PEPs Group. Cuesta MJ, et al. Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. Epub 2015 Mar 26. Schizophr Res. 2015. PMID: 25819935
Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory.
Bonnin CM, Reinares M, Martínez-Arán A, Balanzá-Martínez V, Sole B, Torrent C, Tabarés-Seisdedos R, García-Portilla MP, Ibáñez A, Amann BL, Arango C, Ayuso-Mateos JL, Crespo JM, González-Pinto A, Colom F, Vieta E; CIBERSAM Functional Remediation Group. Bonnin CM, et al. Among authors: ibanez a. Psychol Med. 2016 Jan;46(2):291-301. doi: 10.1017/S0033291715001713. Epub 2015 Sep 21. Psychol Med. 2016. PMID: 26387583 Free article. Clinical Trial.
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
Bioque M, Llerena A, Cabrera B, Mezquida G, Lobo A, González-Pinto A, Díaz-Caneja CM, Corripio I, Aguilar EJ, Bulbena A, Castro-Fornieles J, Vieta E, Lafuente A, Mas S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M; PEPs GROUP. Bioque M, et al. Int J Neuropsychopharmacol. 2016 Mar 31;19(4):pyv121. doi: 10.1093/ijnp/pyv121. Print 2016 Apr. Int J Neuropsychopharmacol. 2016. PMID: 26506856 Free PMC article.
Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome.
Bonnin CM, Torrent C, Arango C, Amann BL, Solé B, González-Pinto A, Crespo JM, Tabarés-Seisdedos R, Reinares M, Ayuso-Mateos JL, García-Portilla MP, Ibañez Á, Salamero M, Vieta E, Martinez-Aran A; CIBERSAM Functional Remediation Group. Bonnin CM, et al. Among authors: ibanez a. Br J Psychiatry. 2016 Jan;208(1):87-93. doi: 10.1192/bjp.bp.114.162123. Epub 2015 Nov 5. Br J Psychiatry. 2016. PMID: 26541692 Clinical Trial.
Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study.
Sanchez-Moreno J, Bonnín C, González-Pinto A, Amann BL, Solé B, Balanzá-Martínez V, Arango C, Jimenez E, Tabarés-Seisdedos R, Garcia-Portilla MP, Ibáñez A, Crespo JM, Ayuso-Mateos JL, Vieta E, Martinez-Aran A, Torrent C; CIBERSAM Functional Remediation Group. Sanchez-Moreno J, et al. Among authors: ibanez a. Eur Neuropsychopharmacol. 2017 Apr;27(4):350-359. doi: 10.1016/j.euroneuro.2017.01.010. Epub 2017 Jan 23. Eur Neuropsychopharmacol. 2017. PMID: 28126401
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M; PEPs Group. Mezquida G, et al. Among authors: ibanez a. Schizophr Res. 2017 Nov;189:84-90. doi: 10.1016/j.schres.2017.01.047. Epub 2017 Feb 6. Schizophr Res. 2017. PMID: 28185786
881 results